LSTM Home > LSTM Research > LSTM Online Archive

Presentations and Outcomes of Central Nervous System TB in a UK Cohort: The high burden of neurological morbidity

Logan, Clare, Feasey, Nicholas ORCID: https://orcid.org/0000-0003-4041-1405, Cosgrove, Catherine, Mullender, Claire, Mirfenderesky, Miriam, Riley, Peter, Houston, Angela, Bicanic, Tihana, Harrison, Tom, Rich, Phil, Hart, Paul, Molloy, Sile and Macallan, Derek (2021) 'Presentations and Outcomes of Central Nervous System TB in a UK Cohort: The high burden of neurological morbidity'. Journal of Infection, Vol 82, Issue 1, pp. 90-97.

[img]
Preview
Text
YJINF-D-20-04006_R1-2.pdf - Accepted Version

Download (1MB) | Preview

Abstract

Objectives
Most data for Central Nervous System Tuberculosis (CNS-TB) derive from high-incidence, resource-limited countries. We sought to determine the presentation, management and outcomes of CNS-TB in a low-incidence setting with accessible healthcare.
Methods
We undertook a retrospective, observational study of CNS-TB in adults at a single tertiary-referral London hospital (2001-2017). Cases were categorised as either TB meningitis (TBM) or TB mass lesions without meningitis (TBML), applying novel criteria for definite, probable, and possible TBML.
Results
We identified sixty-two cases of TBM (37% definite; 31% probable; 32% possible) alongside 14 TBML cases (36% definite; 29% probable; and 36% possible). Clinical presentation was highly variable. Among CSF parameters, hypoglycorrhachia proved most discriminatory for “definite” TBM. Neurosurgical intervention was required for mass-effect or hydrocephalus in 16%. Mortality was higher in TBM versus TBML (16%vs 0%) but overall morbidity was significant; 35% of TBM and 28% of TBML survivors suffered persisting neurological disability at 12-months. Hydrocephalus, infarct, basal enhancement and low CSF white cell count were independently associated with worse neurological outcomes.
Conclusion
Although mortality was lower than previously reported in other settings, morbidity was significant, highlighting the need for improved CNS-TB diagnostics, therapeutics and interventions to mitigate neurological sequelae.

Item Type: Article
Subjects: WF Respiratory System > Tuberculosis > WF 200 Tuberculosis (General)
WF Respiratory System > Tuberculosis > WF 220 Diagnosis. Prognosis
WL Nervous System > WL 100 General works
WL Nervous System > WL 20 Research (General)
Faculty: Department: Clinical Sciences & International Health > Clinical Sciences Department
Digital Object Identifer (DOI): https://doi.org/10.1016/j.jinf.2020.10.028
Depositing User: Marie Hatton
Date Deposited: 04 Nov 2020 12:08
Last Modified: 30 Oct 2021 01:02
URI: https://archive.lstmed.ac.uk/id/eprint/15912

Statistics

View details

Actions (login required)

Edit Item Edit Item